Kinesio taping for chronic breast and truncal oedema after breast cancer treatment
Official title: Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Breast Cancer Treatment: A Randomized Controlled Trial
Run by Universiteit Antwerpen · NCT07080476 · Data updated 2026-11-12
This trial tests whether adding kinesio tape to standard decongestive lymphatic therapy helps women with persistent (more than 6 months) breast or truncal swelling after breast cancer treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 128 (estimated) |
| Sponsor | Universiteit Antwerpen Academic / other |
| Locations | 4 sites (Antwerp and 3 other locations) |
| Status | Recruiting |
| Started | August 25, 2025 |
| Main results expected | April 30, 2028 |
| Study ends | December 2028 |
| Registry record updated | September 3, 2025 |
| Trial ID | NCT07080476 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women previously treated for breast cancer who have persistent (≥6 months) breast and/or truncal oedema with objective signs (BrEQ ≥9 and PWC above specified thresholds), who have not had a mastectomy, do not have metastatic disease, have no skin infections, and can read Dutch are ideal candidates.
✕Probably not a fit
Patients who have had a mastectomy, have metastatic disease, have active skin infections or wounds that prevent tape application, cannot read Dutch, or whose swelling began less than six months after treatment are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
About 128 women with persistent breast and/or truncal oedema will be randomly assigned to receive standard decongestive lymphatic therapy (DLT) alone or DLT plus kinesio taping. The active treatment phase lasts 4 weeks with two sessions per week, followed by a 6-month follow-up to track durability of effects and cost-related outcomes. Outcomes include symptom burden (BrEQ), local tissue water (PWC), pain (VAS), and quality of life (EQ-5D-5L and EORTC-QLQ-BR23). Three embedded sub-studies will examine the longitudinal effect of DLT, the responsiveness of the BrEQ questionnaire, and a compression-bra sub-study.
Why it matters
Potential benefit: If successful, adding kinesio tape could reduce pain and swelling and improve quality of life for women with persistent post-treatment breast or truncal oedema.
How similar studies have gone: Decongestive lymphatic therapy is an established treatment, but prior small studies of kinesio taping for lymphedema have shown mixed or inconclusive results, so the additive benefit remains unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Female patients previously treated for breast cancer.
* Suffering from persistent (\>6 months) breast and/or truncal oedema, established at least six months after completion of radiotherapy.
* Objective measurements:
* BrEQ score ≥9.
* PWC (LymphScanner) showing at least one of the following:
* Truncal oedema: ratio ≥ 1.32.
* Breast oedema: ratio ≥ 1.28.
* Local PWC of 52.90%.
* Clinical evaluation:
* At least one positive sign of breast and/or truncal oedema such as:
* Visual swelling compared with the contralateral side.
* Visible imprint of the bra on the skin.
* Peau d'orange appearance on the breast.
Exclusion Criteria:
* Presence of skin infections or wounds of the breast/truncal region at the time of inclusion making it impossible to apply kinesio tape.
* Age under 18 years.
* Not able to read and understand Dutch language.
* Having received mastectomy.
* Metastatic breast cancer.
Where it's running
-
University of Antwerp
Antwerp, Belgium Recruiting -
Iridium Network
Antwerp, Belgium Recruiting -
Ghent University Hospital
Ghent, Belgium Recruiting -
AZ Groeninge
Kortrijk, Belgium Recruiting
Study contacts
- Study coordinator: Tessa De Vrieze, Phd pt postdoctoral fellow
- Email: tessa.devrieze@uantwerpen.be
- Phone: +32 472 74 16 77
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ESWT added to standard lymphedema care for breast cancer patients
This study tests whether adding extracorporeal shock wave therapy to standard lymphedema care helps women with unilateral Stage II breast cancer–related swelling.
-
Pneumatic compression versus manual lymph drainage as part of decongestive care for breast cancer–related lymphedema
This study tests whether adding or replacing manual lymph drainage with intermittent pneumatic compression helps women with unilateral breast cancer–related arm lymphedema.
-
Effects of physiotherapy on sleep and quality of life in women with lymphedema after breast cancer
This study is testing whether special physiotherapy can help women with lymphedema after breast cancer feel better and sleep more soundly.
-
Using light therapy to manage lymphedema in breast cancer patients
This study is testing if a combination of light therapy and massage can help breast cancer patients with lymphedema reduce swelling, relieve pain, and improve their quality of life.
-
Predicting lymphedema risk in breast cancer patients
This study is testing a new tool to help doctors predict which breast cancer patients are at risk for developing lymphedema after surgery so they can take steps to prevent it.
-
Gentle Touch therapy for arm lymphedema after breast cancer surgery
We will test whether adding Gentle Touch lymphatic drainage to usual rehabilitation reduces arm swelling in women aged 30–75 with breast cancer–related lymphedema.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.